Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 16851-16900 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT03587740
ATOP TRIAL: T-DM1 in HER2 Positive Breast Cancer
PHASE2
Active, not recruiting
82 participants
Started: Aug 22, 2018 · Completed: Aug 30, 2029
1 condition
3 sponsors
14 locations
NCT03601923
Niraparib in Patients With Pancreatic Cancer
PHASE2
Active, not recruiting
32 participants
Started: Aug 22, 2018 · Completed: Feb 28, 2026
1 condition
2 sponsors
3 locations
NCT03839706
Relationship Between 18FDG PET/MRI Patterns and ctDNA to Predict HCC Recurrence After Liver Transplantation
NA
Active, not recruiting
20 participants
Started: Aug 22, 2018 · Completed: Sep 30, 2024
1 condition
1 sponsor
1 location
NCT03643510
Evaluating Cancer Response to Treatment With Abemaciclib and Fulvestrant in Women With Recurrent Endometrial Cancer
PHASE2
Active, not recruiting
28 participants
Started: Aug 21, 2018 · Completed: Aug 31, 2026
1 condition
2 sponsors
7 locations
NCT03635229
Risk Factor of POD and POCD After Cardiac Surgery
N/A
Active, not recruiting
360 participants
Started: Aug 21, 2018 · Completed: Dec 31, 2023
2 conditions
1 sponsor
1 location
NCT03560752
CMV-MVA Triplex Vaccination of Stem Cell Donors in Preventing CMV Viremia in Participants With Allogeneic Transplant
PHASE1
Active, not recruiting
34 participants
Started: Aug 20, 2018 · Completed: Aug 27, 2025
14 conditions
2 sponsors
1 location
NCT06308822
Testing JNJ-42756493 (Erdafitinib) as Potentially Targeting Treatment in Cancers With FGFR Amplifications (MATCH-Subprotocol K1)
PHASE2
Active, not recruiting
35 participants
Started: Aug 20, 2018 · Completed: Dec 31, 2025
5 conditions
1 sponsor
1 location
NCT03678441
Electronic Neurocognitive Tools in Screening for Mental Capability in Patients Undergoing Liver Surgery
NA
Active, not recruiting
100 participants
Started: Aug 17, 2018 · Completed: Apr 30, 2027
1 condition
2 sponsors
1 location
NCT03587662
Ixazomib, Gemcitabine, and Doxorubicin in Treating Patients With Locally Advanced or Metastatic Kidney Cancer
PHASE2
Active, not recruiting
30 participants
Started: Aug 17, 2018 · Completed: Jan 31, 2027
5 conditions
2 sponsors
1 location
NCT03490565
PREoperativ Study of Exercise Training
NA
Active, not recruiting
310 participants
Started: Aug 16, 2018 · Completed: Dec 31, 2028
1 condition
4 sponsors
1 location
NCT03363217
Trametinib for Pediatric Neuro-oncology Patients With Refractory Tumor and Activation of the MAPK/ERK Pathway.
PHASE2
Active, not recruiting
114 participants
Started: Aug 16, 2018 · Completed: Mar 1, 2027
3 conditions
3 sponsors
7 locations
NCT03456076
A Study Comparing Adjuvant Alectinib Versus Adjuvant Platinum-Based Chemotherapy in Patients With ALK Positive Non-Small Cell Lung Cancer
PHASE3
Active, not recruiting
257 participants
Started: Aug 16, 2018 · Completed: Nov 19, 2026
1 condition
1 sponsor
114 locations
NCT03447808
Daratumumab and Ibrutinib in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia
PHASE1
Active, not recruiting
15 participants
Started: Aug 16, 2018 · Completed: Apr 15, 2026
1 condition
1 sponsor
1 location
NCT03371667
To Compare the Efficacy of the Addition of Methotrexate (MTX) to Current Standard Acute Graft-versus-host Disease (GVHD) First-line Treatment With Corticosteroids
PHASE3
Active, not recruiting
102 participants
Started: Aug 16, 2018 · Completed: Dec 31, 2024
4 conditions
1 sponsor
1 location
NCT03709784
Spinraza in Adult Spinal Muscular Atrophy
N/A
Active, not recruiting
148 participants
Started: Aug 16, 2018 · Completed: Jan 1, 2025
3 conditions
1 sponsor
11 locations
NCT03793478
Safety and Efficacy of Quizartinib in Children and Young Adults With Acute Myeloid Leukemia (AML), a Cancer of the Blood
PHASE1/PHASE2
Active, not recruiting
65 participants
Started: Aug 15, 2018 · Completed: May 1, 2027
1 condition
3 sponsors
27 locations
NCT03389230
Memory-Enriched T Cells in Treating Patients With Recurrent or Refractory Grade III-IV Glioma
PHASE1
Active, not recruiting
29 participants
Started: Aug 14, 2018 · Completed: Jan 12, 2026
5 conditions
2 sponsors
1 location
NCT03502733
Testing the Combination of Copanlisib, Nivolumab and Ipilimumab in Patients With Advanced Cancer and Lymphoma
PHASE1
Active, not recruiting
64 participants
Started: Aug 14, 2018 · Completed: Jul 1, 2026
4 conditions
1 sponsor
3 locations
NCT04326946
International Alfapump Cohort Study
N/A
Active, not recruiting
400 participants
Started: Aug 14, 2018 · Completed: Dec 31, 2030
2 conditions
1 sponsor
2 locations
NCT03603951
A Phase 1 Study of SHR2554 in Subjects With Relapsed or Refractory Mature Lymphoid Neoplasms
PHASE1
Active, not recruiting
272 participants
Started: Aug 14, 2018 · Completed: Aug 14, 2026
1 condition
2 sponsors
1 location
NCT03432520
Long-Term Safety and Efficacy of Spark-Sponsored Gene Therapies in Males With Hemophilia A
N/A
Active, not recruiting
29 participants
Started: Aug 14, 2018 · Completed: Dec 31, 2032
1 condition
1 sponsor
12 locations
NCT03673787
A Trial of Ipatasertib in Combination With Atezolizumab
PHASE1/PHASE2
Active, not recruiting
87 participants
Started: Aug 13, 2018 · Completed: Mar 31, 2026
3 conditions
2 sponsors
1 location
NCT03635892
A Study of Nivolumab In Combination With Cabozantinib in Patients With Non-Clear Cell Renal Cell Carcinoma
PHASE2
Active, not recruiting
60 participants
Started: Aug 13, 2018 · Completed: Aug 31, 2026
7 conditions
1 sponsor
7 locations
NCT04703738
Evaluation of Geistlich Fibro-Gide® in Comparison to CTG for the Treatment Around Implants
NA
Active, not recruiting
60 participants
Started: Aug 13, 2018 · Completed: Dec 31, 2025
1 condition
2 sponsors
5 locations
NCT03569293
Evaluation of Upadacitinib in Adolescent and Adult Patients With Moderate to Severe Atopic Dermatitis (Eczema)
PHASE3
Active, not recruiting
912 participants
Started: Aug 13, 2018 · Completed: Oct 9, 2025
1 condition
1 sponsor
180 locations
NCT03631017
Imaging With a PET Agent for Detection of Cancers of the Head and Neck
PHASE1/PHASE2
Active, not recruiting
12 participants
Started: Aug 10, 2018 · Completed: Aug 31, 2026
1 condition
1 sponsor
1 location
NCT03563716
A Study of Tiragolumab in Combination With Atezolizumab in Chemotherapy-Naïve Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
PHASE2
Active, not recruiting
135 participants
Started: Aug 10, 2018 · Completed: Aug 31, 2025
1 condition
1 sponsor
37 locations
NCT03552718
QUILT-2.025 NANT Neoepitope Yeast Vaccine (YE-NEO-001): Adjuvant Immunotherapy Using a Personalized Neoepitope Yeast-Based Vaccine To Induce T-Cell Responses In Subjects W/ Previously Treated Cancers.
PHASE1
Active, not recruiting
16 participants
Started: Aug 10, 2018 · Completed: Dec 30, 2025
7 conditions
1 sponsor
1 location
NCT04139343
Motor Unit Number Estimation (MUNE) in Adults With Spinal Muscular Atrophy (SMA)
N/A
Active, not recruiting
140 participants
Started: Aug 10, 2018 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT03563248
Losartan and Nivolumab in Combination With FOLFIRINOX and SBRT in Localized Pancreatic Cancer
PHASE2
Active, not recruiting
168 participants
Started: Aug 10, 2018 · Completed: Apr 30, 2027
1 condition
4 sponsors
10 locations
NCT03480061
Dexmedetomidine to Reduce the Incidence of POCD After Open Cardiac Surgery
PHASE4
Active, not recruiting
90 participants
Started: Aug 9, 2018 · Completed: Dec 31, 2026
5 conditions
1 sponsor
1 location
NCT03278925
Defined Green Tea Catechin Extract in Preventing Liver Cancer in Participants With Cirrhosis
PHASE1
Active, not recruiting
14 participants
Started: Aug 9, 2018 · Completed: Dec 31, 2024
1 condition
1 sponsor
2 locations
NCT03529110
DS-8201a Versus T-DM1 for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive, Unresectable and/or Metastatic Breast Cancer Previously Treated With Trastuzumab and Taxane [DESTINY-Breast03]
PHASE3
Active, not recruiting
524 participants
Started: Aug 9, 2018 · Completed: Jul 30, 2026
1 condition
3 sponsors
164 locations
NCT03575910
HEARTBiT: Multi-Marker Blood Test for Acute Cardiac Transplant Rejection
N/A
Active, not recruiting
196 participants
Started: Aug 9, 2018 · Completed: Dec 30, 2025
6 conditions
7 sponsors
4 locations
NCT03526432
Phase II Study of Atezolizumab + Bevacizumab in Endometrial Cancer
PHASE2
Active, not recruiting
110 participants
Started: Aug 8, 2018 · Completed: Sep 30, 2025
1 condition
2 sponsors
3 locations
NCT04888702
Holter of Movement in Patients with SMA Undergoing Treatment.
NA
Active, not recruiting
30 participants
Started: Aug 8, 2018 · Completed: May 30, 2025
1 condition
5 sponsors
3 locations
NCT03536767
Open-Label Study of AG10 in Patients with Cardiomyopathy
PHASE2
Active, not recruiting
55 participants
Started: Aug 8, 2018 · Completed: Jul 31, 2027
1 condition
1 sponsor
9 locations
NCT03576378
BrEPEM-LH-22017 for Older Patients With Untreated Hodgkin Lymphoma (HL)
PHASE1/PHASE2
Active, not recruiting
41 participants
Started: Aug 8, 2018 · Completed: Oct 30, 2024
1 condition
2 sponsors
15 locations
NCT03580928
Acalabrutinib, Venetoclax, and Obinutuzumab for Initial Therapy of CLL
PHASE2
Active, not recruiting
72 participants
Started: Aug 7, 2018 · Completed: Dec 31, 2027
1 condition
5 sponsors
4 locations
NCT04646850
Long-term Treatment With the Ketogenic Diet in Epilepsy
N/A
Active, not recruiting
30 participants
Started: Aug 6, 2018 · Completed: Dec 31, 2025
3 conditions
1 sponsor
1 location
NCT04638465
De-Escalation Protocol Of HPV Mediated Oropharyngeal Squamous Cell Carcinoma
N/A
Active, not recruiting
150 participants
Started: Aug 6, 2018 · Completed: Jan 31, 2030
2 conditions
1 sponsor
1 location
NCT03612531
Manual Therapy in Treating Fibrosis-Related Late Effect Dysphagia in Head and Neck Cancer Survivors
NA
Active, not recruiting
24 participants
Started: Aug 6, 2018 · Completed: Dec 31, 2025
4 conditions
2 sponsors
1 location
NCT03504644
Venetoclax and Vincristine in Treating Patients With Relapsed or Refractory T-cell or B-cell Acute Lymphoblastic Leukemia
PHASE1/PHASE2
Active, not recruiting
74 participants
Started: Aug 3, 2018 · Completed: Dec 31, 2028
9 conditions
2 sponsors
170 locations
NCT03236935
Phase Ib of L-NMMA and Pembrolizumab
PHASE1
Active, not recruiting
12 participants
Started: Aug 3, 2018 · Completed: Dec 28, 2025
6 conditions
1 sponsor
1 location
NCT03593811
Noninvasive Markers of Functional Nausea in Children
EARLY_PHASE1
Active, not recruiting
42 participants
Started: Aug 3, 2018 · Completed: Aug 31, 2026
1 condition
1 sponsor
1 location
NCT03634267
MRI-Guided Brachytherapy in Treating Participants With HPV-Associated Stage IB2-IVA Cervical or Stage II-IVA Vaginal Cancer
PHASE1
Active, not recruiting
26 participants
Started: Aug 3, 2018 · Completed: Dec 31, 2026
17 conditions
2 sponsors
1 location
NCT03618537
Ixazomib Maintenance Study in Patients With AL Amyloidosis
PHASE2
Active, not recruiting
17 participants
Started: Aug 2, 2018 · Completed: Aug 31, 2026
1 condition
3 sponsors
8 locations
NCT03343431
Antiviral Prophylaxis and Infant Vaccination to Prevent Perinatal Hepatitis B Infection
PHASE3
Active, not recruiting
504 participants
Started: Aug 2, 2018 · Completed: Jun 30, 2025
2 conditions
4 sponsors
20 locations
NCT03525873
A Study of Cancer Related Fatigue in Patients With Metastatic Cancer Receiving Anti-PD1 Immunotherapy
PHASE3
Active, not recruiting
212 participants
Started: Aug 2, 2018 · Completed: Dec 31, 2026
3 conditions
2 sponsors
1 location
NCT06335394
Prospective Study in Adults Evaluating Safety & Efficacy of NVD003 for Bone Reconstruction to Treat Lower Limb Nonunion
PHASE1/PHASE2
Active, not recruiting
11 participants
Started: Aug 2, 2018 · Completed: May 15, 2028
1 condition
1 sponsor
10 locations
Previous
1
More pages
335
336
337
338
339
340
341
More pages
431
Next